Lim, C.-H.; Fang, X.-Q.; Kang, H.; Oh, T.; Lee, S.; Kim, Y.-S.; Lim, J.-H.
ER Stress-Activated HSF1 Governs Cancer Cell Resistance to USP7 Inhibitor-Based Chemotherapy through the PERK Pathway. Int. J. Mol. Sci. 2024, 25, 2768.
https://doi.org/10.3390/ijms25052768
AMA Style
Lim C-H, Fang X-Q, Kang H, Oh T, Lee S, Kim Y-S, Lim J-H.
ER Stress-Activated HSF1 Governs Cancer Cell Resistance to USP7 Inhibitor-Based Chemotherapy through the PERK Pathway. International Journal of Molecular Sciences. 2024; 25(5):2768.
https://doi.org/10.3390/ijms25052768
Chicago/Turabian Style
Lim, Chang-Hoon, Xue-Quan Fang, Hyeji Kang, Taerim Oh, Seonghoon Lee, Young-Seon Kim, and Ji-Hong Lim.
2024. "ER Stress-Activated HSF1 Governs Cancer Cell Resistance to USP7 Inhibitor-Based Chemotherapy through the PERK Pathway" International Journal of Molecular Sciences 25, no. 5: 2768.
https://doi.org/10.3390/ijms25052768
APA Style
Lim, C.-H., Fang, X.-Q., Kang, H., Oh, T., Lee, S., Kim, Y.-S., & Lim, J.-H.
(2024). ER Stress-Activated HSF1 Governs Cancer Cell Resistance to USP7 Inhibitor-Based Chemotherapy through the PERK Pathway. International Journal of Molecular Sciences, 25(5), 2768.
https://doi.org/10.3390/ijms25052768
